X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213064
https://www.escardio.org/The-ESC/Press-Office/Press-releases/Edoxaban-noninferior-to-warfarin-for-adverse-events-after-heart-valve-replacement
https://www.prnewswire.com/news-releases/new-12-month-analysis-data-from-etna-af-non-interventional-study-show-low-bleeding-and-ich-rates-in-frail-and-ageing-af-patients-on-lixiana-edoxaban-during-routine-clinical-care-301120876.html
https://www.prnewswire.com/news-releases/new-12-month-analysis-data-from-etna-af-non-interventional-study-show-low-bleeding-and-ich-rates-in-frail-and-ageing-af-patients-on-lixiana-edoxaban-during-routine-clinical-care-301120876.html
https://www.prnewswire.com/news-releases/etna-af-europe-registry-data-on-lixianaedoxaban-published-in-a-leading-cardiology-journal-highlights-important-clinical-considerations-for-treating-ageing-patients-with-atrial-fibrillation-301115029.html
https://www.prnewswire.com/news-releases/rates-of-bleeding-and-venous-thromboembolism-vte-events-reported-after-12-months-of-edoxaban--treatment-considered-low-by-real-world-etna-vte-study-investigators-301093021.html
https://www.prnewswire.com/news-releases/european-results-from-global-etna-af-registry-show-low-bleeding-and-low-cardiovascular-event-rates-in-elderly-nvaf-patients-on-lixiana-edoxaban-300937477.html
https://www.clinicaltrialsarena.com/news/daiichi-sankyo-lixiana-iiib-results/
https://www.prnewswire.com/news-releases/daiichi-sankyo-presents-positive-results-of-the-entrust-af-pci-study-of-lixiana-edoxaban-in-patients-with-atrial-fibrillation-300911022.html
https://www.raps.org/news-and-articles/news-articles/2019/8/daiichi-sankyo-bayer-otsuka-and-others-called-ou
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-edoxaban-tosylate-1552998056.pdf
https://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/UCM293268.pdf
https://www.ema.europa.eu/documents/regulatory-procedural-guideline/list-centrally-authorised-products-requiring-notification-change-update-annexes_en-0.pdf
http://www.prnewswire.co.uk/news-releases/daiichi-sankyo-presents-first-snapshot-analyses-from-global-etna-af-programme-of-oral-once-daily-691864891.html
https://www.businesswire.com/news/home/20180628005468/en/Daiichi-Sankyo-Menarini-Enter-Exclusive-Licensing-Agreement
https://endpts.com/following-fda-win-portola-loses-ceo-william-lis/
https://www.fiercepharma.com/manufacturing/portola-s-andexxa-bleeding-antidote-wins-fda-nod-but-will-get-limited-release
https://www.fiercepharma.com/pharma/daiichi-sankyo-makes-another-big-whack-at-u-s-sales-operation-280-to-go
https://www.pharmacompass.com/pdf/news/daiichi-sankyo-europe-gmbh-roteas-edoxaban-receives-approval-in-europe-1493959462.pdf
http://www.prnewswire.com/news-releases/daiichi-sankyo-inc-announces-new-analyses-of-once-daily-savaysa-edoxaban-in-patients-with-non-valvular-atrial-fibrillation-to-be-presented-at-the-acc-66th-annual-scientific-session-300422143.html
http://www.pharmatimes.com/news/six_new_medicines_endorsed_for_eu_approval_1187675
http://www.fiercepharma.com/pharma/daiichi-caps-layoffs-drive-by-melding-nj-ops-into-one-smaller-hq
http://www.fiercepharmamarketing.com/story/hoping-jump-start-lixiana-daiichi-sankyo-taps-merck-european-market-assault/2016-02-22
http://www.biospectrumasia.com/biospectrum/news/223030/daiichi-sankyo-inks-marketing-pact-daewoong-pharmaceutical
http://www.pharmatimes.com/Article/15-11-10/Four_therapies_approved_for_use_on_NHS_Scotland.aspx
http://www.europeanpharmaceuticalreview.com/35179/news/industry-news/nice-recommends-blood-thinning-drug-edoxaban/?
http://www.europeanpharmaceuticalreview.com/34350/news/industry-news/nice-recommends-edoxaban-for-deep-vein-thrombosis/?
http://www.fiercepharma.com/story/daiichi-clot-buster-wins-nice-green-light-still-faces-uphill-track/2015-08-12
http://www.pharmatimes.com/Article/15-07-10/UK_launch_for_Daiichi_s_bloodthinner_Lixiana.aspx
http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/002629/WC500189048.pdf
http://www.daiichisankyo.com/media_investors/media_relations/press_releases/detail/006314.html
http://www.pmlive.com/pharma_news/bms_opdivo_backed_as_melanoma_therapy_in_eu_721486
http://www.pharmatimes.com/Article/15-04-26/Eleven_medicines_leap_closer_to_approval_in_Europe.aspx
http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/04/news_detail_002310.jsp&mid=WC0b01ac058004d5c1
Market Place
Share 
